Agentic identity management for healthcare AI agents and governance

At a glance

What this is: Imprivata is framing agentic identity management as a way to govern healthcare AI agents with managed identities, least privilege, short-lived tokens, and continuous oversight.

Why it matters: This matters because healthcare IAM teams now have to extend governance, monitoring, and accountability controls to software that acts inside clinical and operational workflows.

Context

Healthcare AI agents are moving from support tasks into regulated workflows such as clinical documentation, patient triage, care coordination, and prescription processing. That shift changes the identity problem from user access management to identity governance for software that can act inside clinical systems.

The governance gap is straightforward: traditional IAM assumes a known human or service account pattern, while agentic systems may initiate actions across modern and legacy platforms in real time. In healthcare, that creates direct pressure on patient safety, compliance, and operational resilience.

Imprivata's announcement is therefore less about a new interface and more about a new governance model for AI agents in environments that already carry strict access, audit, and availability requirements.

Key questions

Q: How should healthcare teams govern AI agents that access clinical systems?

A: Treat AI agents as managed identities with named ownership, scoped permissions, audit trails, and revocation. In healthcare, the governance bar should be higher than for ordinary automation because agents can touch regulated workflows, patient data, and legacy systems. Combine least privilege with human oversight for actions that could affect care delivery or privacy.

Q: Why do AI-enabled healthcare tools increase non-human identity risk?

A: AI-enabled tools usually need broad, always-on access to data, services, and workflows to function at scale. That increases the number of credentials to manage and the chance that one identity is granted more reach than it truly needs. The risk grows when permissions are inherited from operations rather than designed for the specific use case.

Q: What signals show that an AI agent is operating outside its intended purpose?

A: Look for mismatches across identity, data, model behaviour, posture, and environment. A clean authorization trail is not enough if the agent starts touching unrelated data, follows injected instructions, drifts from its known configuration, or continues acting in a way that does not fit the task.

Q: What should teams do when an AI agent must access both modern and legacy healthcare systems?

A: Use a brokered access model that enforces the same identity controls across both environments, rather than granting separate exceptions for each platform. The key is to preserve consistent authentication, least privilege, and revocation so the agent cannot become a hidden bridge between incompatible systems.

How it works in practice

Why healthcare AI agents need managed identities

AI agents in healthcare are not just another automation layer. When they authenticate to clinical systems, trigger workflows, or access patient data, they behave like non-human identities and should be governed that way. Managed identity treatment means the organisation can assign roles, permissions, audit trails, and revocation paths to the agent itself rather than relying on the surrounding application to contain it. The technical change is important because the agent becomes a distinct security principal with its own lifecycle, not a feature buried in a clinical tool.

Practical implication: inventory healthcare AI agents as identities, not as application features, so access can be granted and revoked explicitly.

How short-lived tokens and least privilege reduce agent exposure

Short-lived tokens narrow the window in which an agent can reuse credentials after a task completes or a workflow changes. Least privilege then limits the systems, records, and actions the agent can reach if it is misused, misconfigured, or manipulated through prompt injection. In regulated healthcare environments, that combination matters because excessive scope can quickly turn a useful workflow helper into a source of patient data exposure or operational disruption. The control objective is to make each agent session narrow, visible, and revocable.

Practical implication: bind each agent task to a minimal access scope and time-bound credential so token reuse cannot outlive the workflow.

Why real-time monitoring and registries matter for governance

A registry of authorised agents gives security teams a baseline for what should exist, while discovery of unmanaged agents shows what has escaped governance. Real-time monitoring then turns that inventory into active control by showing which systems the agent touched, what actions it took, and whether the behaviour matched its approved role. In healthcare, this is especially important because legacy platforms often make it difficult to infer identity context later. Without live visibility, you only find misuse after the clinical or operational impact has already spread.

Practical implication: maintain an authorised agent registry and monitor live activity so unsanctioned or overreaching agents can be contained quickly.

NHI Mgmt Group analysis

Agentic identity management is becoming a healthcare governance pattern, not a product feature. The important shift is that AI agents now need the same identity treatment as other non-human actors when they reach into regulated systems. That means roles, permissions, auditability, and revocation must be designed around the agent's behaviour, not around the application that launched it. The practical conclusion is that healthcare IAM programmes need an explicit identity class for agents.

The least-privilege model in healthcare fails if the actor can change tasks faster than governance can review them. Traditional access design assumes a stable principal and a bounded workflow. Agentic systems break that assumption because they can move across documentation, triage, scheduling, and pharmacy-related steps inside one operational loop. Practitioners should treat scope drift as a governance fault line, not as an edge case.

Managed identity controls for agents are now part of patient safety and operational resilience. In healthcare, identity is not only about proving who or what is allowed in. It also determines whether an automated action can propagate into clinical decisions, data integrity issues, or service disruption. The implication is that healthcare identity teams must coordinate IAM, PAM, security operations, and clinical governance around the same agent registry and monitoring model.

Zero Trust for healthcare AI agents is only credible when access is brokered continuously. A one-time approval model is too brittle when agents interact with legacy EHRs and modern systems in the same environment. Continuous verification, short-lived access, and live revocation are the real controls that preserve accountability. Practitioners should re-evaluate whether their current access stack can broker agent activity at the pace healthcare workflows require.

Identity governance for AI agents will increasingly define how quickly healthcare organisations can adopt automation safely. The organisations that can classify agents, monitor them, and constrain them across modern and legacy systems will move faster with less exposure. Those that keep treating agent access as a temporary exception will create shadow pathways into clinical infrastructure. The operational decision is no longer whether to govern agents, but how quickly the governance model can be made explicit.

From our research library:

• 69% of security leaders agree identity management must fundamentally shift to address agentic AI systems, according to the 2026 Infrastructure Identity Survey.
• 53% of security leaders expect AI to run major portions of their infrastructure autonomously within the next three years, according to the 2026 Infrastructure Identity Survey.
• Read next: Top 10 Agentic AI Identity Issues

What this signals

Authorised agent inventory is now a control plane issue. Healthcare teams cannot rely on application owners to keep track of which AI agents are active, what they can reach, and whether they still have a valid purpose. The registry has to become part of identity governance, not an informal list kept outside the control stack.

Access review alone is too slow for agentic workflows. If an AI agent can request, use, and release access inside a single clinical or operational cycle, there may be nothing meaningful left to recertify after the fact. The governance model needs issuance-time controls and live monitoring, not only periodic review.

Cross-environment access will be the stress test for healthcare AI identity. Legacy systems, modern EHRs, and operational platforms rarely share the same control patterns, so agent identity has to be brokered consistently across all three. That is where Zero Trust principles and privileged access discipline become operational rather than theoretical.

For practitioners

• Define AI agents as governed identities Create a distinct identity category for healthcare AI agents with named owners, approved purposes, and explicit access boundaries. Do not fold them into generic application accounts or temporary automation labels.
• Issue short-lived access for each workflow Use time-bound credentials or tokens that end with the task, session, or clinical process the agent was authorised to perform. Avoid persistent access that can be reused across unrelated systems or cases.
• Maintain an authorised agent registry Track every approved agent, the systems it can reach, and the business function it supports. Remove anything that cannot be tied to an owner, purpose, or control path.
• Monitor and audit agent actions in real time Log the systems touched, data accessed, and actions executed by each agent so that security and clinical governance can see behaviour as it happens. Use the monitoring feed to revoke or narrow access when behaviour drifts.

Key takeaways

• Healthcare AI agents are emerging as a distinct identity class that must be governed with the same seriousness as other non-human identities.
• The risk is not only unauthorized access, but also patient safety, operational disruption, and weakened accountability when agent behaviour is not continuously controlled.
• The most relevant control shift is from after-the-fact review to issuance-time scope control, live monitoring, and rapid revocation.

Key terms

• Agentic Identity Governance: The discipline of managing, governing, and auditing the identities of autonomous AI agents across their full lifecycle, from provisioning with least-privilege credentials through continuous monitoring and decommissioning. An emerging sub-discipline of NHI governance.
• Managed Identity: A cloud-provider-managed identity assigned to a compute resource, allowing it to authenticate to cloud services without storing credentials in application code.
• Short-Lived Scoped Token: A short-lived scoped token is an access credential that expires quickly and only authorizes specific actions or resources. For MCP, it is the practical boundary that replaces standing access with task-limited permission, reducing blast radius when a client or agent is compromised.
• Agent Registry: An agent registry is a central catalog of sanctioned and shadow AI agents, including their identities, permissions, and lifecycle state. Its value depends on whether it feeds broader governance, because a registry without telemetry, ownership, and offboarding can become another silo.

Deepen your knowledge

NHI governance, agentic AI identity, and machine identity lifecycle are core topics in our NHI Foundation Level course, the industry's only accredited NHI security programme. If you are building or maturing an IAM programme, it is worth exploring.